Onesource Specialty Pharma Q2 Results
- BSE: 544292
- NSE: ONESOURCE
- ISIN: INE013P01021
- Sector: Biotechnology & Drugs
BSE
1,706
-32.15 (-1.85%)
-32.15 (-1.85%)Volume7.44 K
Updated: Tue 9 Jun, 2026 | 11:29:05
NSE
1,720.40-17.40 (-1.00%)
-17.40 (-1.00%)Volume57.82 K
Updated: Tue 9 Jun, 2026 | 11:14:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Onesource Specialty Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 339.09 | 309.46 | 9.58% | 330.33 | 2.65% |
| Depreciation/ Amortization | 69.83 | 67.80 | 2.99% | 68.28 | 2.26% |
| Operating Income | 36.67 | 17.81 | 105.87% | 3.72 | 885.70% |
| Net Income | 10.49 | -0.19 | 0.00% | -42.08 | 0.00% |
| Other Operating Expenses Total | 92.96 | 87.43 | 6.32% | 78.34 | 18.65% |
| Net Income Before Taxes | 5.74 | -4.40 | 0.00% | -37.45 | 0.00% |
| Total Revenue | 375.76 | 327.27 | 14.82% | 334.05 | 12.49% |
| Selling/ General/ Admin Expenses Total | 62.82 | 58.44 | 7.50% | 53.98 | 16.38% |
| Diluted Normalized EPS | 0.91 | 0.18 | 403.90% | -3.54 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.